Weight Loss | Specialist Doctors https://specialistdoctors.com Universe of Doctors, Patients and Pharmacies around the Globe Tue, 21 Jul 2026 09:00:06 +0000 en-US hourly 1 https://wordpress.org/?v=7.0.2 How to encourage to try vegetables in meals https://specialistdoctors.com/how-to-encourage-to-try-vegetables-in-meals/ Tue, 21 Jul 2026 09:00:06 +0000 https://specialistdoctors.com/?p=2793 Summer holidays often bring mealtime struggles as parents coax children to eat more vegetables. Many families face daily battles over broccoli or other greens, yet simple strategies can turn tension into enjoyment while supporting children’s growth and nutrition.

Parents report success by disguising or pairing vegetables creatively. Fry green beans or cauliflower in a little butter, coat with breadcrumbs, and serve as nuggets for a familiar crunch. Blend vegetables into pasta sauces or pesto for hidden nutrition, or mix them into favourite dishes like curries and spaghetti Bolognese. Homemade burgers loaded with grated vegetables also appeal to young taste buds. These approaches boost intake of vitamins, fibre and antioxidants essential for immunity and digestion without creating conflict.

Routine helps during unstructured holidays. Visual boards showing upcoming snacks and activities reduce anxiety for some children. Offer multiple healthy choices so kids feel in control, and always include familiar vegetables on the plate even if untouched. Praise any interest shown, such as requesting carrots, to build positive associations.

Research indicates children may need up to 15 exposures before accepting new foods, so persistence pays off. Avoid forcing clean plates, which can create pressure and long-term resistance. Instead, model calm enjoyment of meals yourself.

Note that sensory issues linked to special educational needs differ from typical fussiness and may require tailored professional advice. Consistent, low-pressure exposure helps most children develop lifelong healthy eating habits that protect against future health concerns.

]]>
Scientists discover natural hormone that help treat obesity https://specialistdoctors.com/scientists-discover-natural-hormone-that-help-treat-obesity/ Tue, 21 Jul 2026 06:41:38 +0000 https://specialistdoctors.com/?p=2586 In a groundbreaking study from the University of Oklahoma, researchers have elucidated the mechanism by which the naturally occurring hormone fibroblast growth factor 21 (FGF21) reverses obesity in mice, offering promising insights for human therapeutics. Published in *Cell Reports*, the findings reveal that FGF21 exerts its effects by signaling to the hindbrain, specifically targeting the nucleus of the solitary tract (NTS) and area postrema (AP), which then relay signals to the parabrachial nucleus. This neural circuit enhances metabolic activity, promoting energy expenditure and fat burning, rather than solely suppressing appetite—a key distinction from glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide, which primarily act on similar hindbrain regions to reduce food intake. Lead researcher Matthew Potthoff, PhD, emphasized the surprise in discovering this pathway, as prior assumptions pointed to the hypothalamus for weight regulation. For Indian doctors managing the rising epidemic of obesity and related comorbidities—where over 135 million Indians are affected according to recent ICMR data—this mechanism highlights FGF21 as a potential target for novel interventions. Unlike GLP-1 analogs, which can cause gastrointestinal side effects and bone loss, FGF21’s focus on metabolism could lead to safer, more targeted therapies, particularly relevant in a population with high prevalence of metabolic syndrome and non-alcoholic fatty liver disease (NAFLD), now termed metabolic dysfunction-associated steatohepatitis (MASH).

The study builds on FGF21’s established role in metabolic regulation, with analogs already in clinical trials for MASH, a condition linked to obesity and type 2 diabetes that affects up to 30% of Indian adults with diabetes. By mapping this brain circuit, the research paves the way for developing FGF21-based drugs that minimize adverse effects while effectively combating obesity and liver pathology. Potthoff’s team notes that while the current work centers on weight loss, further investigations are needed to confirm the circuit’s role in reversing MASH. This discovery aligns with global efforts to address obesity, a major public health challenge in India, where urbanization and dietary shifts have escalated rates. For specialists, integrating such hormonal insights could enhance multidisciplinary approaches, combining pharmacotherapy with lifestyle interventions. Overall, this advances our understanding of neuroendocrine control of metabolism, potentially revolutionizing treatment paradigms for obesity-related disorders.

 

]]>
Scientists reveal how seven days of fasting transforms the human body https://specialistdoctors.com/scientists-reveal-how-seven-days-of-fasting-transforms-the-human-body/ Mon, 20 Jul 2026 14:38:07 +0000 https://specialistdoctors.com/?p=2642 A recent study published in *Nature Metabolism* provides one of the most detailed molecular maps of prolonged fasting in humans. Researchers at Queen Mary University of London tracked 12 healthy volunteers during a seven-day water-only fast using daily proteomics analysis of approximately 3,000 circulating proteins. The body switched from glucose to fat oxidation within 48–72 hours, producing an average 5.7 kg weight loss. Most lean-mass loss was restored after three days of refeeding, while fat loss was largely retained. The most pronounced systemic changes, however, emerged only after day three and involved more than one-third of measured proteins, particularly those regulating the extracellular matrix, neuronal support structures, and inflammatory pathways. These coordinated shifts suggest that clinically relevant metabolic, immune, and potential neuroprotective effects require sustained caloric restriction beyond the shorter windows used in most intermittent-fasting regimens.

For Indian clinicians, the findings reinforce both opportunity and caution. Prolonged fasting appears to modulate pathways linked to insulin sensitivity, lipid metabolism, and low-grade inflammation, offering a mechanistic basis for observed benefits in metabolic disorders. At the same time, the study recorded transient rises in platelet-activation and clotting-related proteins, underscoring risks of electrolyte imbalance, dehydration, and muscle loss. Extended fasting should therefore be considered only under medical supervision and is contraindicated in patients with diabetes, cardiovascular disease, or eating disorders. The data also support future development of fasting-mimetic therapies that could deliver similar molecular effects without requiring complete food deprivation.

 

]]>
Simple habits may help you lose weight https://specialistdoctors.com/simple-habits-may-help-you-lose-weight/ Thu, 09 Apr 2026 06:24:30 +0000 https://specialistdoctors.com/?p=2319 A recent study published in *Health Psychology* by the American Psychological Association highlights the potential benefits of maintaining consistent eating habits for weight loss. Researchers analyzed data from 112 overweight or obese adults participating in a 12-week behavioral weight loss program, where participants tracked their food intake via a mobile app and daily weigh-ins. The findings revealed that individuals who adhered to structured routines—such as repeating similar meals and maintaining stable daily calorie intake—achieved greater weight loss outcomes. Specifically, those with high dietary repetition lost an average of 5.9% of their body weight, compared to 4.3% for those with more varied diets. Additionally, for every 100-calorie fluctuation in daily intake, weight loss decreased by approximately 0.6%. Lead author Charlotte Hagerman, PhD, from the Oregon Research Institute, emphasized that such routines reduce the cognitive burden of self-control in today’s challenging food environment, making healthy choices more automatic and sustainable. This approach contrasts with traditional advice promoting dietary variety, which may be more suitable in healthier food landscapes but could hinder consistency in modern settings laden with processed options.

For Indian doctors, these insights are particularly relevant in managing patients with obesity, a growing concern amid rising rates of metabolic disorders in urban and rural populations. The study notes a correlation rather than causation, suggesting that factors like motivation and self-discipline may also play roles. An intriguing observation was that participants reporting higher calorie intake on weekends (likely due to more accurate tracking) still experienced better results, underscoring the importance of reliable self-monitoring. While variety within nutrient-dense food groups like fruits and vegetables remains beneficial for overall health, simplifying meal choices—such as recommending a rotation of balanced, culturally appropriate Indian meals (e.g., consistent portions of dal, roti, and vegetables)—could enhance adherence in clinical weight management programs. However, physicians should advise patients to ensure nutritional balance to avoid deficiencies, and integrate this with personalized counseling, exercise, and monitoring for comorbidities. This strategy may empower patients to build long-term habits, potentially improving outcomes in resource-limited settings where access to diverse healthy foods varies.

 

]]>
Weight Loss in Postmenopausal Women : Lost 35% more weight https://specialistdoctors.com/weight-loss-in-postmenopausal-women-lost-35-more-weight/ Sat, 04 Apr 2026 09:37:07 +0000 https://specialistdoctors.com/?p=2316 Recent Mayo Clinic-led observational study, published in The Lancet Obstetrics, Gynaecology, & Women’s Health, has revealed promising insights into obesity management for postmenopausal women. The research analyzed data from 120 adults with overweight or obesity treated with tirzepatide—a GLP-1 receptor agonist approved by the US FDA for weight management and type 2 diabetes—for at least 12 months. Notably, postmenopausal women concurrently using menopausal hormone therapy (MHT) experienced approximately 35% greater weight loss compared to those on tirzepatide alone. This finding is particularly relevant for Indian doctors, as menopause-related weight gain affects a significant proportion of women in India, where rising obesity rates contribute to cardiometabolic comorbidities. Menopause often leads to estrogen decline, promoting visceral fat accumulation and elevating risks for cardiovascular disease and type 2 diabetes. The study suggests that MHT, which is the gold standard for alleviating vasomotor symptoms like hot flashes affecting up to 75% of postmenopausal women, may synergize with tirzepatide’s appetite-suppressing effects. Preclinical evidence supports this, indicating estrogen could enhance GLP-1 pathways, potentially improving adherence to lifestyle interventions through better sleep and quality of life. Lead author Regina Castaneda, M.D., emphasized the need for personalized strategies to mitigate cardiometabolic risks in this demographic, highlighting the study’s observational nature and the possibility that healthier behaviors among MHT users influenced outcomes.

While the results are clinically meaningful, senior author Maria Daniela Hurtado Andrade, M.D., Ph.D., cautioned that causation cannot be inferred without randomized trials, as factors like symptom relief might indirectly support weight loss. This opens avenues for Indian endocrinologists and gynecologists to consider integrated approaches, especially in a context where cultural and socioeconomic factors influence menopause management. Future research, funded by the Mayo Clinic Center for Women’s Health Research, aims to validate these observations through controlled trials, exploring broader benefits on cardiometabolic markers. Such advancements could inform evidence-based protocols, potentially reducing obesity-related burdens in India’s aging female population and accelerating adoption of combined therapies. Indian specialists should monitor emerging data, weighing MHT’s benefits against risks like thromboembolism, and tailor treatments based on individual profiles.

 

]]>